Equities analysts expect National Health Investors, Inc. (NYSE:NHI) to report $1.38 earnings per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for National Health Investors’ earnings. The highest EPS estimate is $1.38 and the lowest is $1.37. National Health Investors reported earnings of $1.32 per share in the same quarter last year, which indicates a positive year over year growth rate of 4.5%. The firm is expected to announce its next earnings report on Wednesday, August 8th.
On average, analysts expect that National Health Investors will report full year earnings of $5.50 per share for the current financial year, with EPS estimates ranging from $5.48 to $5.53. For the next year, analysts expect that the company will report earnings of $5.65 per share, with EPS estimates ranging from $5.57 to $5.70. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover National Health Investors.
National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Tuesday, May 8th. The real estate investment trust reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.34 by ($0.42). The business had revenue of $72.75 million for the quarter, compared to the consensus estimate of $72.04 million. National Health Investors had a net margin of 53.88% and a return on equity of 11.69%. National Health Investors’s revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.25 EPS.
Several brokerages recently weighed in on NHI. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of National Health Investors in a research report on Wednesday, May 16th. Capital One raised shares of National Health Investors from an “equal weight” rating to an “overweight” rating in a research report on Friday, May 11th. KeyCorp cut their price objective on shares of National Health Investors from $70.00 to $60.00 and set a “sell” rating on the stock in a research report on Tuesday, April 17th. BMO Capital Markets set a $70.00 price objective on shares of National Health Investors and gave the company a “hold” rating in a research report on Monday, March 26th. Finally, Mizuho reaffirmed a “hold” rating and set a $70.00 price objective on shares of National Health Investors in a research report on Monday, February 26th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $73.25.
A number of hedge funds have recently made changes to their positions in the business. Allianz Asset Management GmbH grew its holdings in National Health Investors by 7.8% during the first quarter. Allianz Asset Management GmbH now owns 572,100 shares of the real estate investment trust’s stock valued at $38,497,000 after purchasing an additional 41,300 shares during the last quarter. Principal Financial Group Inc. grew its holdings in National Health Investors by 7,076.6% during the first quarter. Principal Financial Group Inc. now owns 506,594 shares of the real estate investment trust’s stock valued at $34,089,000 after purchasing an additional 499,535 shares during the last quarter. WINTON GROUP Ltd acquired a new position in National Health Investors during the first quarter valued at approximately $715,000. Xact Kapitalforvaltning AB grew its holdings in National Health Investors by 37.3% during the first quarter. Xact Kapitalforvaltning AB now owns 5,151 shares of the real estate investment trust’s stock valued at $347,000 after purchasing an additional 1,400 shares during the last quarter. Finally, Legal & General Group Plc grew its holdings in National Health Investors by 10.7% during the first quarter. Legal & General Group Plc now owns 133,324 shares of the real estate investment trust’s stock valued at $8,971,000 after purchasing an additional 12,889 shares during the last quarter. Institutional investors own 70.02% of the company’s stock.
National Health Investors traded up $0.52, hitting $72.26, during midday trading on Friday, according to MarketBeat. 104,523 shares of the company’s stock traded hands, compared to its average volume of 194,555. The firm has a market cap of $2.98 billion, a PE ratio of 13.56, a PEG ratio of 3.72 and a beta of 0.42. The company has a debt-to-equity ratio of 0.88, a quick ratio of 15.21 and a current ratio of 15.21. National Health Investors has a one year low of $62.71 and a one year high of $81.60.
The business also recently declared a quarterly dividend, which will be paid on Friday, August 10th. Shareholders of record on Friday, June 29th will be issued a dividend of $1.00 per share. The ex-dividend date of this dividend is Thursday, June 28th. This represents a $4.00 annualized dividend and a yield of 5.54%. National Health Investors’s dividend payout ratio (DPR) is presently 75.05%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.